Cancer Information Highlights, June 6, 2018

National Cancer Institute sent this bulletin at 06/06/2018 12:42 PM EDT
National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share
Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
 
New from NCI
Most Women with Early Breast Cancer Do Not Benefit from Chemotherapy
doctor and patient, talking   New findings from a groundbreaking phase 3 clinical trial show that most women with a common type of breast cancer do not benefit from chemotherapy. Read about this important study and learn which patients are most likely to benefit from these findings.
Video—Risk Factors for Cancer
Screen shot from video of woman applying sun screen   Watch the Did You Know? Risk Factors for Cancer video to learn how age, weight, exposure to carcinogens, and genetics can increase the risk of developing cancer.
New Treatment Approach Could Help Prevent Recurrences of Some Bladder Cancers

Read about this practice-changing clinical trial that found that flushing the bladder with a chemotherapy drug called gemcitabine (Gemzar) after surgery may reduce the risk of the cancer returning.
NCI-MATCH Releases New Findings

The NCI-MATCH precision medicine clinical trial has reached a milestone with the release of results from several of the study's treatment arms. The findings were presented at the 2018 American Society of Clinical Oncology annual meeting, adding to findings from one arm released in 2017.
Can Immunotherapy Be Effective against Glioblastoma?
Glioblastoma cells   Despite continued efforts to develop new therapies for glioblastoma, none have been able to increase how long patients live. Even so, researchers are hopeful that immunotherapy might be effective where other therapies have not.
Easing Concerns About Returning Genetic Test Results

Learn about a recent study involving women with a history of breast cancer that tested an approach for returning genetic research results and evaluated the effect those results had on the women.
Second CAR T-Cell Therapy for Lymphoma Approved

The Food and Drug Administration (FDA) has approved a second CAR T-cell therapy for certain kinds of non-Hodgkin lymphoma. Read about the trial that led to the approval and what it means for people with lymphoma.
PDQ Summary Updates
Staging for Pancreatic and Thyroid Cancers

We’ve revised our PDQ summaries on Pancreatic Cancer Treatment and Thyroid Cancer Treatment with updated descriptions and new illustrations of the different stages of these diseases.
 
Also of Interest
Male Breast Cancer

Breast cancer in men is rare, but it does occur. Learn about some of the known risk factors for this cancer, how it is diagnosed and treated, and the things that affect the chances of recovery.
Immunotherapy to Treat Cancer

During Cancer Immunotherapy Awareness Month, learn the basics about this cancer treatment. Read about the types of immunotherapy, how they work against cancer, and side effects they might cause.
Advanced Cancer and Caregivers

As a caregiver, you go through cancer along with the patient. This page takes you to resources to help you understand the special challenges you face, tips for taking care of yourself, and things to think about to help you plan for the future.